| Literature DB >> 28597109 |
Rumana J Khan1, Samson Y Gebreab2, Pia R Crespo2, Ruihua Xu2, Amadou Gaye2, Sharon K Davis2.
Abstract
PURPOSE: Poor health-related quality of life (HRQOL) could lead to higher morbidity and mortality through telomere attrition or accelerated cellular aging. We conducted a cross-sectional analysis to examine the relationship between four dimensions of HRQOL and leukocyte telomere length (LTL) among a nationally representative sample of 3547 US adults (≥20 years) using the data from the 2001-2002 National Health and Nutrition Examination Survey.Entities:
Keywords: Aging; Health-related quality of life; Leukocyte telomere length; Perceived health status; Race
Mesh:
Year: 2017 PMID: 28597109 PMCID: PMC5597687 DOI: 10.1007/s11136-017-1610-9
Source DB: PubMed Journal: Qual Life Res ISSN: 0962-9343 Impact factor: 4.147
Demographic characteristics and telomere length of US adult population by race (National Health Interview Survey, 2001–2002, N = 3547)
| White ( | Black ( | Mexican American ( | |
|---|---|---|---|
| Age in yearsa | 46.89 (45.71–48.08) | 41.99 (40.42–43.56) | 37.57 (35.99–39.14) |
| Gender | |||
| Male | 49.96 (48.51–51.48) | 44.98 (41.21–48.74) | 51.78 (48.67–54.89) |
| Female | 50.03 (48.58–51.48) | 55.01 (51.25–58.78) | 48.21 (45.10–51.32) |
| Education | |||
| Less than high school | 12.92 (9.94–15.90) | 32.38 (25.26–39.49) | 51.47 (45.36–57.59) |
| More than high school | 87.07 (84.09–90.05) | 67.61 (60.50–74.73) | 48.52 (42.40–54.63) |
| Marital status | |||
| Married or partnered | 69.57 (66.99–72.16) | 47.64 (43.98–51.23) | 70.49 (65.53–75.27) |
| Telomere length in base pairsa,b | 5854.34 (5741.23–5967.45) | 6001.31 (5858.69–6143.92) | 5900.65 (5818.87–5982.42) |
| Age-adjusted telomere Length in base pairsa,b,c | 5864.35 (5845.96–5882.75) | 5940.27 (5916.00–5964.55) | 6008.86 (5984.47–6033.24) |
| Smoked at least 100 cigarettes in life | 51.68 (46.35–57.01) | 43.77 (38.82–48.72) | 42.00 (36.92–47.08) |
| Had at least 12 alcohol drinks in any one year | 76.59 (67.26–85.92) | 59.65 (52.48–66.83) | 67.16 (62.45–71.88) |
| Vigorous physical activity over past 30 days | 39.38 (35.26–43.49) | 30.94 (26.25–35.63) | 33.75 (29.29–38.21) |
| Obesityd | 29.57 (26.28–32.85) | 40.56 (36.16–44.95) | 29.91 (24.59–35.24) |
| Known diabetes | 6.82 (5.74–7.90) | 10.75 (8.04–13.45) | 8.72 (7.62–9.81) |
| Known hypertension | 25.71 (22.82–28.59) | 36.88 (33.62–40.14) | 11.96 (10.38–13.55) |
| Known congestive heart failure | 1.98 (1.05–2.92) | 2.91 (1.41–4.41) | 1.09 (0.3–1.88) |
| Known cancer or malignancy | 9.97 (8.09–11.86) | 3.24 (2.37–4.11) | 1.79 (0.73–2.86) |
Analyses were done with adjustment for sample weights and design effects
Data represent percentage (95% confidence interval), except where noted
aMean (95% confidence interval)
bCalculated using formula “3274 + 2413 × T/S ratio (telomere length relative to standard reference DNA)”
cDerived using regression coefficient for age
dDefined as body mass index (weight in kg divided by height in meter square) of 30 or higher
Proportions of responses to four dimensions of health-related quality of life (HRQOL) questions of US adult population by race (National Health Interview Survey, 2001–2002, N = 3547)
| White ( | Black ( | Mexican American ( | |
|---|---|---|---|
| General health | |||
| Excellent/very good | 57.53 (52.74–62.31) | 37.67 (29.54–45.80) | 28.39 (24.17–32.60) |
| Good | 31.01 (26.87–35.15) | 37.48 (32.00–42.96) | 41.21 (36.66–45.77) |
| Poor/fair | 11.45 (9.44–13.46) | 24.84 (17.79–31.88) | 30.39 (26.44–34.33) |
| Unwell physical health during the past 30 days | |||
| 0 days | 62.43 (58.97–65.89) | 60.65 (54.41–66.89) | 65.25 (60.33–70.16) |
| 1–15 days | 31.01 (27.69–34.32) | 30.61 (26.01–35.02) | 29.20 (24.11–34.29) |
| 16–30 days | 6.54 (5.54–7.55) | 8.73 (4.54–12.91) | 5.54 (3.73–7.34) |
| Unwell mental health during the past 30 days | |||
| 0 days | 60.37 (56.38–64.36) | 59.08 (52.64–65.52) | 60.30 (57.44–63.16) |
| 1–15 Days | 32.44 (29.15–35.72) | 30.35 (24.65–36.05) | 34.36 (31.38–37.33) |
| 16–30 days | 7.18 (5.56–8.79) | 10.56 (7.22–13.89) | 5.33 (4.12–6.54) |
| Activity limitation during the past 30 days | |||
| 0 days | 81 (80.21–83.74) | 79.47 (73.92–85.02) | 83.52 (80.64–86.41) |
| 1–15 Days | 15.59 (13.77–17.40) | 15.74 (11.35–20.14) | 14.18 (11.56–16.79) |
| 16–30 days | 2.43 (1.51–3.35) | 4.44 (1.66–7.88) | 2.29 (0.98–3.59) |
Analyses were done with adjustment for sample weights and design effects
Data represent percentage (95% confidence interval)
Fig. 1Estimated mean leukocyte telomere length of US adults by race and four dimensions of health-related quality of life (National Health Interview Survey, 2001–2002, N = 3547). Base pairs (bp) were calculated using the formula “3274 + 2413 × T/S ratio (telomere length relative to standard reference DNA).” Mean calculated with adjustment for sample weights and design effects. Limit lines indicate 95% confidence interval. Abbreviations, Mexican Am Mexican Americans
Association between four dimensions of health-related quality of life measures and log-transformed telomere length in US adults, estimated from multivariate regression models (National Health Interview Survey, 2001–2002, N = 3547)
| General health | Unwell physical health during the past 30 days | Unwell mental health during the past 30 days | Activity limitation during the past 30 days | |||||
|---|---|---|---|---|---|---|---|---|
| β (SE) | β (SE) | β (SE) | β (SE) | |||||
| Reference group | Excellent | 0 day | 0 day | 0 day | ||||
| Good | Poor | 1–15 days | 16–30 days | 1–15 days | 16–30 days | 1–15 days | 16–30 days | |
|
| ||||||||
| White | −.007 (.004) | −.001 (.006) | − | −.005* (.002) | .0001 (.002) | .002 (.005) | −.003 (.003) | .003 (.007) |
| Black | − | −.007 (.004) | −.009* (.004) | −.002 (.006) | −.006 (.004) | −.005 (.005) | .001 (.002) | −.004 (.005) |
| Mexican American | −.007 (.004) | −.001 (.009) | .001 (.002) | .010 (.006) | .0001 (.003) | .011 (.006) | −.005 (.003) | .017 (.011) |
|
| ||||||||
| White | −.007 (.004) | −.001 (.005) | − | -.005* (.002) | .0002 (.002) | .002 (.005) | −.003 (.003) | .004 (.007) |
| Black | − | −.007 (.005) | −.009* (.005) | −.004 (.006) | −.006 (.004) | −.005 (.005) | .001 (.002) | −.004 (.006) |
| Mexican American | −.007 (.004) | −.0006 (.009) | .002 (.002) | .011 (.006) | −.0001 (.003) | .009 (.006) | −.004 (.002) | .017 (.010) |
|
| ||||||||
| White | −.007 (.004) | .001 (.006) | − | −.003 (.003) | .0003 (.002) | .003 (.006) | −.002 (.003) | .007 (.006) |
| Black | − | −.006 (.005) | −.009* (.004) | −.004 (.006) | −.007 (.004) | −.006 (.005) | .0002 (.003) | −.005 (.006) |
| Mexican American | .002 (.002) | .011 (.006) | −.006 (.004) | .002 (.009) | −.0004 (.003) | .013 (.005) | −.004 (.003) | .018 (.010) |
Values are multivariable adjusted β coefficients, with linearized standard errors (SE) in parentheses
Estimated with adjustment for sample weights for the genetic subsample and design effects
Boldface indicates statistical significance (P values: *** p value ≤ 0.01, ** p value ≤ 0.05, * p value ≤ 0.10)
aAdjusted for age, gender, education, marital status
bAdjusted for age, gender, education, marital status, hypertension, diabetes, obesity, cancer status, congestive heart failure
cAdjusted for age, gender, education, marital status, hypertension, diabetes, obesity, cancer status, congestive heart failure, smoking status, physical activity, and alcohol intake